MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,822,149 | -2.3% | 3,738,100 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $4,934,292 | +192.6% | 3,738,100 | +56.7% | 0.01% | +125.0% |
| Q1 2023 | $1,686,381 | +5.3% | 2,385,600 | +11.7% | 0.00% | -33.3% |
| Q4 2022 | $1,601,700 | -12.9% | 2,135,600 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $1,839,000 | -5.4% | 2,135,600 | +23.0% | 0.01% | +20.0% |
| Q2 2022 | $1,944,000 | -10.3% | 1,735,600 | -10.3% | 0.01% | +25.0% |
| Q1 2022 | $2,168,000 | -30.0% | 1,935,600 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $3,097,000 | -33.9% | 1,935,600 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $4,684,000 | -23.7% | 1,935,600 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $6,136,000 | -5.9% | 1,935,600 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $6,523,000 | -5.9% | 1,935,600 | 0.0% | 0.01% | -9.1% |
| Q4 2020 | $6,929,000 | – | 1,935,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,029,649 | $12,331,000 | 0.54% |
| Vivo Capital, LLC | 778,000 | $2,381,000 | 0.17% |
| Logos Global Management LP | 200,000 | $612,000 | 0.12% |
| DAFNA Capital Management LLC | 76,800 | $235,000 | 0.07% |
| Verition Fund Management LLC | 395,290 | $1,210,000 | 0.04% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 250,000 | $765,000 | 0.02% |
| CSS LLC/IL | 54,773 | $168,000 | 0.01% |
| Point72 Asset Management, L.P. | 375,000 | $1,148,000 | 0.01% |
| Marshall Wace North America L.P. | 267,180 | $818,000 | 0.01% |
| Jefferies Group LLC | 90,000 | $275,000 | 0.00% |